Krishna Institute of Medical Sciences Ltd Q1 FY26 Results

Summary

Krishna Institute of Medical Sciences Ltd. reported its financial results for the first quarter of the financial year 2026, ending on 30th June 2025. The company recorded a total revenue of INR 879 Cr, marking a growth of 26.8% on a year-over-year (YoY) basis and 9.6% on a quarter-over-quarter (QoQ) basis. EBITDA stood at INR 200 Cr, with a growth of 8.5% YoY and a de-growth of 1.4% QoQ. EBITDA margin was reported at 22.7%, down from 26.6% in Q1 FY25 and 25.3% in Q4 FY25. Consolidated EPS for Q1 FY26 was INR 1.96, showing a de-growth of 9.2% YoY.

Key Highlights

1. 1

   Total revenue of INR 879 Cr, a growth of 26.8% YoY and 9.6% QoQ

2. 2

   EBITDA of INR 200 Cr, a growth of 8.5% YoY and a de-growth of 1.4% QoQ

3. 3

   EBITDA margin at 22.7% vs. 26.6% in Q1 FY25 and 25.3% in Q4 FY25

4. 4

   PAT at INR 85 Cr in Q1 FY26 against INR 95 Cr and INR 106 Cr in Q1 FY25 and Q4 FY25 respectively

5. 5

   Consolidated Revenue from Operations of INR 872 Cr, a growth of 26.6% on YoY and 9.4% on QoQ

6. 6

   Consolidated EBITDA (Pre-INDAS) of INR 194 Cr, a growth of 9.8% on YoY and a de-growth of 1.5% on QoQ

7. 7

   ARPOB grew by 11.8% and 3.7% on YoY and QoQ basis respectively

8. 8

   ARPP grew by 9.8% and 2.7% on YoY and QoQ basis respectively